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Conduct disorder (CD) and aggressive behaviour in children 
and adolescents show an increasing prevalence in Western 
societies [4, 8]. Children and adolescents dropping out of 
school or living in youth welfare institutions show a particu-
larly high rate of CD, oppositional and aggressive behaviour 
[3]. CD and aggressive behaviour show phenotypic over-
lap, but are also distinct entities. Aggressive behaviour is 
a symptom of many psychiatric disorders, and also is an 
adaptive human behaviour related to the chance to survive. 
CD is a defined psychiatric disorder which comprises symp-
toms additional to aggression including rule breaking and 
dissocial behaviour, and can only be diagnosed if the related 
behaviour causes impairment for the individual and/or his/
her family. CD poses a strong risk for detrimental adult out-
comes, affecting individuals, their families, and society as a 
whole. Longitudinal studies following CD youth into early 
adulthood have found increased rates of failure to complete 
high school, high rates of early pregnancy, substance abuse, 
criminality, and health-related problems [5, 7]. In females 
with CD, additionally, high rates of early pregnancy have 
been described [9]. While evidence-based international 
clinical guidelines, which summarize the current state of 
the art regarding diagnosis and intervention of CD, such 
as NICE [10], emphasize a strong evidence for interven-
tions in childhood; research on effective treatments of CD 
and aggressive behaviour in adolescence, and on preven-
tive measures for detrimental adult outcomes is still in its 
infancy. Our understanding of the underlying neurobiology 
of CD remains rudimentary, and predictors of longitudinal 
outcomes associated with CD and aggression have rarely 
been studied despite their clinical and societal impact [6].
In 2013, within the 7th Framework for Research (FP7), 
the European Commission called for applications for 
“Paediatric conduct disorders characterized by aggressive 
traits and/or social impairment: from preclinical research 
to treatment”. Four large research and innovation projects 
were funded with a total of over 20 million Euro: ACTION 
(coordinator Dorret Boomsma), AGGRESSOTYPE (coordi-
nator Barbara Franke), FemNAT-CD (coordinator Christine 
M. Freitag), and MATRICS (coordinator Jeffrey Glennon).
The ACTION consortium (Aggression in Children: 
Unravelling gene–environment interplay to inform Treat-
ment and InterventiON strategies) includes genome-wide 
association meta-analysis (GWAMA) of longitudinal aggres-
sion and attention problems in twin and population cohorts; 
and epigenetic genome-wide association (EWAS) meta-
analysis of aggression in children and adults, and related 
genotype–environment studies. A “biomarker in urine” 
project looks both at classical biomarkers for aggression 
and at biomarkers from multiple metabolomics platforms. 
Metabolites from a range of chemical classes and biochemi-
cal pathways were tested for stability within an individual 
and suitability for predicting aggression. ACTION includes 
large-scale epidemiological and outcome studies making use 
of existing childhood data in twins, birth cohorts and clinical 
samples, and the population data from Sweden (homepage: 
www.actio n-eupro ject.eu).
Aggressotype (aggression subtyping for improved insight 
and treatment innovation in paediatric psychiatric disorders) 
uses subtyping of aggression into impulsive and instrumen-
tal to guide its approaches. Through coordinated analyses in 
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humans and different (human-induced pluripotent stem cell 
derived, zebrafish, and mouse) models, aggression aetiol-
ogy as it applies to ADHD and paediatric conduct disor-
der was studied. Different levels from molecule to system 
were investigated: DNA (genetics, epigenetics), RNA (gene 
expression), neural circuits (neuroimaging), cognition (neu-
ropsychology), behaviour, and diagnosis. A second layer of 
work is dedicated to predicting, preventing, and treating 
aggression. Here, interdisciplinary data integration is used 
to design predictive algorithms and identify biomarkers. 
Non-pharmacological biofeedback in aggressive children is 
explored as early intervention, and methylphenidate is tested 
for its application in the psychiatric care of criminal offend-
ers (homepage: www.aggre ssoty pe.eu).
The FemNAT-CD consortium (Neurobiology and Treat-
ment of Adolescent Female Conduct Disorder: The Central 
Role of Emotion Processing) focusses on female adoles-
cent CD and the role of emotion processing in CD. A large 
(N > 1800) case–control sample was collected within the 
study, with multi-level genetic, epigenetic, endocrinologi-
cal, neurophysiological, neurocognitive, and brain imaging 
data available. The broad phenotypic assessment, including 
all comorbid psychiatric disorders, as well as data on envi-
ronmental risk factors will allow delineating CD aetiologies 
and subtypes. In addition, a randomized controlled interven-
tion study on a program based on dialectic behavioural and 
trauma-sensitive methods for females with CD/ODD living 
in youth welfare institutions (START Now) has been cur-
rently finalized. Targeted pharmaco-challenge and animal 
studies focus on oxytocin challenge and serotonergic com-
pounds to study their role in emotion processing (homepage: 
www.femna t-cd.eu).
MATRICS (Multidisciplinary Approaches to Translational 
Research In Conduct Syndromes) examines the interplay 
between arousal dysregulation and failure of top-down 
control processes over emotional and cognitive processing 
resulting in aggression and rule-breaking behaviour. This 
is studied in human-induced pluripotent stem cell-derived 
neurons, patients with oppositional-defiant disorder (ODD) 
or CD, and animal models with altered stress reactivity 
resulting in epigenetic and transcriptomic regulators (DNA 
methylation, microRNA) as key molecular underpinnings in 
both animal and human data sets. Using Bayesian machine 
learning approaches, the dependencies between different 
cognitive domains and gene–environment interactions are 
investigated, while bio-/neuro-feedback approaches are uti-
lized to train juveniles with CD on how to cope with their 
reactivity to triggers. MATRICS also examines the cogni-
tive underpinnings of a range of pharmacological interven-
tions (methylphenidate, dexamphetamine, atomoxetine, 
risperidone, aripiprazole, and oxytocin) to alter cognitive 
and emotional reactivity in rodents and those with ODD/CD 
(homepage: www.matri cs-proje ct.eu).
The four consortia are committed to collaborate wher-
ever possible, and the present focused issue in European 
Child + Adolescent Psychiatry (ECAP) is one example of 
such collaboration. Since the projects are running between 
2013 and 2019, work in progress is reported in this issue. 
In December 2017, the EC invited the four consortia to 
a policy workshop in Brussels organized by the EC’s 
health research directorate, namely Andreas Holtel and 
colleagues. The consortia presented research outputs that 
‘call for translation’ in terms of guideline development 
regarding treatment recommendations, and uptake by pub-
lic health, policy makers, and/or by industry for the devel-
opment of new products or product development tools. A 
wealth of emerging findings showed good potential for 
societal and/or industrial impact. The EC summarized that 
“EU-funded conduct disorder and aggression research is 
a convincing showcase for what can be achieved, if com-
plementary research efforts are bundled under a common 
concept and strategies tailored to the respective research 
area”. Key to justifying EU research support is—apart 
from the European Research Association building objec-
tive—the impact this research generates for patients, 
European societies including European industries. Thus, 
many FP7 and H2020 calls explicitly require translational 
efforts and/or industry involvement. In addition to gauging 
the potential, the workshop in Brussels aimed at learning 
which obstacles to successful translation are being encoun-
tered and to discuss which possible remedies and support 
measures could be envisaged. The following aspects were 
presented and discussed at the workshop:
1. Preclinical animal models for aggression research (stud-
ied by AGGRESSOTYPE, FemNAT-CD, and MAT-
RICS).
2. New biomarker options based on distinct biological aeti-
ologies: genetic and epigenetic developmental trajecto-
ries (studied by ACTION, Aggressotype, and FemNAT-
CD); biological biomarker discovery in urine (studied by 
ACTION).
3. New intervention options: randomized controlled phase-
III trial on methylphenidate in adult prisoners (studied 
by AGGRESSOTYPE), randomized controlled multi-
centre phase-IIa trial on the START Now-intervention 
in female adolescents (studied by FemNAT-CD); pilot 
phase-IIa studies with methylphenidate, atomoxetine, 
risperidone, and aripiprazole (studied by MATRICS) 
and oxytocin (studied by FemNAT-CD).
4. The role of psychiatric comorbidity in subtyping CD 
with and without callous unemotional traits (studied by 
FemNAT-CD, and MATRICS).
5. Improvement of evidence-based clinical guidelines and 
translating these into practice (studied by ACTION, 
AGGRESSOTYPE, FemNAT-CD, and MATRICS).
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Taken together, the workshop showed that the cluster of 
CD/aggression research consortia has indeed developed into 
a highly interactive research community that presents traits 
of good cluster corporate identity, across confines of indi-
vidual projects. The EC concluded that EU-funded research 
on conduct disorders and aggression is yielding a plethora 
of research findings that are of high translational value and 
hence apt to generate impact on citizens and patients as well 
as on public health systems and the commercial biomedical 
sector. Results from the presented CD/aggression research 
projects call for EU-wide dissemination of results and their 
uptake by public health systems.
It was also recognized that CD research proves to be a 
particularly challenging target area for clinical research, as 
important determinants in the socioeconomic context (fam-
ily situations and/or educational systems) require interdis-
ciplinary research. The pathway from clinical research find-
ings to treatment recommendations and guidelines is not 
sufficiently clear to all actors involved, e.g. with respect to 
valid methodology and requirements of clinical studies. The 
functioning of the public health sector and the importance 
of health economics are not sufficiently accounted for, as 
evidenced, e.g. by the design of studies testing costly inter-
ventions that will not be taken up in a real-life public health 
context.
Research on CD and aggression can be considered as a 
particularly challenging field as:
• CD and aggressive behaviour overlap, but they are not 
synonymous. The nosology of CD and different forms of 
antisocial and aggressive behaviour are not unambigu-
ous; comorbidity is the rule, hence requiring precise 
evidence-based subtyping—a prime area for personalized 
medicine aiming to profile individuals with multidimen-
sional disorders.
• The time span of disorder development is crucial, 
throughout childhood into adolescence and early adult-
hood, and hence longitudinal as well as age-specific stud-
ies are needed.
• Recognition of heterogeneity in the mechanisms leading 
to CD and aggression is needed; many risk factors are 
still unknown. Those that have been identified often have 
low specificity, and we know little about their interplay 
at different levels; in addition, environmental risk factors 
are measured very differently across studies, complicat-
ing comparisons.
• Clear gender-specific manifestations of a range of CD/
aggressive behaviours are found, suggesting the need of 
gender-specific treatment guidelines.
• High-risk target groups present with most severe symp-
toms, hence those with the greatest need of prevention 
and treatment, are the ones most difficult to reach for 
research as well as for interventions.
• Approaches to CD and aggressive maladaptation in pub-
lic health systems are very diverse in different EU coun-
tries, with guidelines, even where available, often not 
being implemented.
• Industry interest in developing new drugs for CD/aggres-
sion is low, partly due to previous failures with drug tri-
als. Enabling framework conditions and support from 
public side are needed to substitute for, or trigger, more 
industry interest.
• The identification of new aetiological models, provid-
ing an entrance to drug and biomarker development, is 
essential.
Given the progress achieved by the four consortia, pre-
sented in this focused issue as well as at the EC workshop, 
researchers, clinicians, as well as stakeholders emphasized 
the need to further support CD and aggression research at 
the EU level.
In this focused issue of ECAP, we present selected works 
from the consortia showing how we deal with some of the 
challenges listed above. We present a review on females with 
CD [[6] (FemNAT-CD)] and several original articles on 
diagnostic, measurement, and treatment aspects of the target 
phenotype [[1] (ACTION); [11] (AGGRESSOTYPE)], lon-
gitudinal genetic and environmental influences on CD and 
aggressive behaviour [[13] (ACTION)], and on cognitive 
aspects of CD [[2] (MATRICS); [12] (FemNAT-CD)]. The 
coordinators of the consortia, which are the guest editors of 
this focused issue, hope you will enjoy this selection.
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